Filing Details
- Accession Number:
- 0001062993-25-011243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-09 16:34:37
- Reporting Period:
- 2025-06-05
- Filing Date:
- 2025-06-09
- Accepted Time:
- 2025-06-09 16:34:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801395 | Paul Blanchfield | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Building Bedford MA 01730 | President | No | Yes | No | No |
Transaction Summary
| Sold: | 6,599 shares | Avg. Price: $79.65 | Total Value: $525,610.35 |
| Number of Shares After Transactions: | 111,792 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-05 | 6,599 | $79.65 | 111,792 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2025.
Billionaire Hedge Funds
